Cholesterol Test Market Research Report - Forecast till 2027

Cholesterol Test Market Research Report: Information by Product Type (Test Kits and Test Strips), Test Type (Total Cholesterol Test, High-Density Lipoprotein (HDL) Cholesterol, Low-Density Lipoprotein (LDL) Cholesterol and Triglycerides/VLDL Cholesterol Test), Distribution Channel (Over the Counter and Prescription Based), End-User (Hospitals & Clinics, Homecare, Diagnostic Centers and others) - Forecast till 2027

ID: MRFR/HC/7266-HCR | August 2022 | Region: Global | 90 Pages         

Table of Contents

1. EXECUTIVE SUMMARY

1.1. Market Attractiveness Analysis

1.1.1. Global Cholesterol Test Market, by Product Type

1.1.2. Global Cholesterol Test Market, by Test Type

1.1.3. Global Cholesterol Test Market, by Distribution Channel

1.1.4. Global Cholesterol Test Market, by End User

1.1.5. Global Cholesterol Test Market, by Region

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.5. Breakdown of Primary Respondents

3.6. Forecasting Techniques

3.7. Research Methodology for Market Size Estimation

3.8. Bottom-Up Approach

3.9. Top-Down Approach

3.10. Data Triangulation

3.11. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porterโ€™s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.2.1. R&D and Designing

5.2.2. Manufacturing

5.2.3. Distribution & Sales

5.2.4. Post Sales Services

6. GLOBAL CHOLESTEROL TEST MARKET, BY PRODUCT TYPE

6.1. Overview

6.2. Test Kits

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3. Test Strips

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7. GLOBAL CHOLESTEROL TEST MARKET, BY TEST TYPE

7.1. Overview

7.2. Total Cholesterol Test

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3. High-density Lipoprotein (HDL) Cholesterol

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4. Low-density Lipoprotein (LDL) Cholesterol

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5. Triglycerides/VLDL Cholesterol Test

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8. GLOBAL CHOLESTEROL TEST MARKET, BY DISTRIBUTION CHANNEL

8.1. Overview

8.2. Over the Counter

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3. Prescription Based

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9. GLOBAL CHOLESTEROL TEST MARKET, BY END USER

9.1. Overview

9.2. Hospitals & Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.3. Homecare

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.4. Diagnostic Centers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.5 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

10. GLOBAL CHOLESTEROL TEST MARKET, BY REGION

10.1. Overview

10.2. Americas

10.2.1. North America

10.2.1.1. US

10.2.1.2. Canada

10.2.2. Latin America

10.3. Europe

10.3.1. Western Europe

10.3.1.1. Germany

10.3.1.2. France

10.3.1.3. Italy

10.3.1.4. Spain

10.3.1.5. UK

10.3.1.6. Rest of Western Europe

10.3.2. Eastern Europe

10.4. Asia-Pacific

10.4.1. Japan

10.4.2. China

10.4.3. India

10.4.4. Australia

10.4.5. South Korea

10.4.6. Rest of Asia-Pacific

10.5. Middle East & Africa

10.5.1. Middle East

10.5.2. Africa

11. COMPANY LANDSCAPE

11.1. Overview

11.2. Competitor Dashboard

11.3. Major Growth Strategy in the Global Cholesterol Test Market

11.4. Competitive Benchmarking

11.5. The Leading Player in terms of Number of Developments in Global Cholesterol Test Market

11.6. Key Developments & Growth Strategies

11.7. Major Players Financial Matrix & Market ratio

12. COMPANY PROFILES

12.1. Quest Diagnostics Incorporated

12.1.1. Company Overview

12.1.2. Products/Services Offered

12.1.3. Financial Overview

12.1.4. Key Developments

12.1.5. SWOT Analysis

12.1.6. Key Strategies

12.2. Cell Biolabs, Inc.

12.3. Clinical Reference Laboratory, Inc.

12.4. Laboratory Corporation of America Holdings

12.5. Randox Laboratories Ltd.

12.6. Thermo Fisher Scientific

12.7. PTS Diagnostics

12.8. Alere Inc.

12.9. F. Hoffmann-La Roche AG

12.10. Eurofins Scientific

12.11. Others

13. APPENDIX

13.1. References

13.2. Related Reports

โ€ƒ

LIST OF TABLES

TABLE 1 GLOBAL CHOLESTEROL TEST MARKET SYNOPSIS, 2020-2027

TABLE 2 GLOBAL CHOLESTEROL TEST MARKET ESTIMATES & FORECAST, 2020-2027 (USD MILLION)

TABLE 3 GLOBAL CHOLESTEROL TEST MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 4 GLOBAL CHOLESTEROL TEST MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)

TABLE 5 GLOBAL CHOLESTEROL TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)

TABLE 6 GLOBAL CHOLESTEROL TEST MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 7 GLOBAL CHOLESTEROL TEST MARKET, BY REGION, 2020-2027 (USD MILLION)

TABLE 8 NORTH AMERICA: CHOLESTEROL TEST MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 9 NORTH AMERICA: CHOLESTEROL TEST MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)

TABLE 10 NORTH AMERICA: CHOLESTEROL TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)

TABLE 11 NORTH AMERICA: CHOLESTEROL TEST MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 12 US: CHOLESTEROL TEST MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 13 US: CHOLESTEROL TEST MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)

TABLE 14 US: CHOLESTEROL TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)

TABLE 15 US: CHOLESTEROL TEST MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 16 CANADA: CHOLESTEROL TEST MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 17 CANADA: CHOLESTEROL TEST MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)

TABLE 18 CANADA: CHOLESTEROL TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION

TABLE 19 CANADA: CHOLESTEROL TEST MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 20 LATIN AMERICA: CHOLESTEROL TEST MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 21 LATIN AMERICA: CHOLESTEROL TEST MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)

TABLE 22 LATIN AMERICA: CHOLESTEROL TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)

TABLE 23 LATIN AMERICA: CHOLESTEROL TEST MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 24 EUROPE: CHOLESTEROL TEST MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 25 EUROPE: CHOLESTEROL TEST MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)

TABLE 26 EUROPE: CHOLESTEROL TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)

TABLE 27 EUROPE: CHOLESTEROL TEST MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 28 WESTERN EUROPE: CHOLESTEROL TEST MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 29 WESTERN EUROPE: CHOLESTEROL TEST MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)

TABLE 30 WESTERN EUROPE: CHOLESTEROL TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)

TABLE 31 WESTERN EUROPE: CHOLESTEROL TEST MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 32 EASTERN EUROPE: CHOLESTEROL TEST MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 33 EASTERN EUROPE: CHOLESTEROL TEST MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)

TABLE 34 EASTERN EUROPE: CHOLESTEROL TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)

TABLE 35 EASTERN EUROPE: CHOLESTEROL TEST MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 36 ASIA-PACIFIC: CHOLESTEROL TEST MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 37 ASIA-PACIFIC: CHOLESTEROL TEST MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)

TABLE 38 ASIA-PACIFIC: CHOLESTEROL TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)

TABLE 39 ASIA-PACIFIC: CHOLESTEROL TEST MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA: CHOLESTEROL TEST MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 41 MIDDLE EAST & AFRICA: CHOLESTEROL TEST MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA: CHOLESTEROL TEST MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA: CHOLESTEROL TEST MARKET, BY END USER, 2020-2027 (USD MILLION) โ€ƒ

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL CHOLESTEROL TEST MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL CHOLESTEROL TEST MARKET

FIGURE 4 GLOBAL CHOLESTEROL TEST MARKET SHARE, BY PRODUCT TYPE, 2020 (%)

FIGURE 5 GLOBAL CHOLESTEROL TEST MARKET SHARE, BY TEST TYPE, 2020 (%)

FIGURE 6 GLOBAL CHOLESTEROL TEST MARKET SHARE, BY DISTRIBUTION CHANNEL, 2020 (%)

FIGURE 7 GLOBAL CHOLESTEROL TEST MARKET SHARE, BY END USER, 2020 (%)

FIGURE 8 GLOBAL CHOLESTEROL TEST MARKET SHARE, BY REGION, 2020 (%)

FIGURE 9 AMERICAS: CHOLESTEROL TEST MARKET SHARE BY REGION, 2020 (%)

FIGURE 10 NORTH AMERICA: CHOLESTEROL TEST MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 11 EUROPE: CHOLESTEROL TEST MARKET SHARE, BY REGION, 2020 (%)

FIGURE 12 WESTERN EUROPE: CHOLESTEROL TEST MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 13 ASIA-PACIFIC: CHOLESTEROL TEST MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 14 MIDDLE EAST & AFRICA: CHOLESTEROL TEST MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 15 GLOBAL CHOLESTEROL TEST MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 16 QUEST DIAGNOSTICS INCORPORATED: KEY FINANCIALS

FIGURE 17 QUEST DIAGNOSTICS INCORPORATED: SEGMENTAL REVENUE

FIGURE 18 QUEST DIAGNOSTICS INCORPORATED: REGIONAL REVENUE

FIGURE 19 CELL BIOLABS, INC.: KEY FINANCIALS

FIGURE 20 CELL BIOLABS, INC.: SEGMENTAL REVENUE

FIGURE 21 CELL BIOLABS, INC.: REGIONAL REVENUE

FIGURE 22 CLINICAL REFERENCE LABORATORY, INC.: KEY FINANCIALS

FIGURE 23 CLINICAL REFERENCE LABORATORY, INC.: SEGMENTAL REVENUE

FIGURE 24 CLINICAL REFERENCE LABORATORY, INC.: REGIONAL REVENUE

FIGURE 25 LABORATORY CORPORATION OF AMERICA HOLDINGS: KEY FINANCIALS

FIGURE 26 LABORATORY CORPORATION OF AMERICA HOLDINGS: SEGMENTAL REVENUE

FIGURE 27 LABORATORY CORPORATION OF AMERICA HOLDINGS: REGIONAL REVENUE

FIGURE 28 RANDOX LABORATORIES LTD.: KEY FINANCIALS

FIGURE 29 RANDOX LABORATORIES LTD.: SEGMENTAL REVENUE

FIGURE 30 RANDOX LABORATORIES LTD.: REGIONAL REVENUE

FIGURE 31 THERMO FISHER SCIENTIFIC: KEY FINANCIALS

FIGURE 32 THERMO FISHER SCIENTIFIC: SEGMENTAL REVENUE

FIGURE 33 THERMO FISHER SCIENTIFIC: REGIONAL REVENUE

FIGURE 34 PTS DIAGNOSTICS.: KEY FINANCIALS

FIGURE 35 PTS DIAGNOSTICS.: SEGMENTAL REVENUE

FIGURE 36 PTS DIAGNOSTICS.: REGIONAL REVENUE

FIGURE 37 ALERE INC.: KEY FINANCIALS

FIGURE 38 ALERE INC.: SEGMENTAL REVENUE

FIGURE 39 ALERE INC.: REGIONAL REVENUE

FIGURE 40 F. HOFFMANN-LA ROCHE AG.: KEY FINANCIALS

FIGURE 41 F. HOFFMANN-LA ROCHE AG.: SEGMENTAL REVENUE

FIGURE 42 F. HOFFMANN-LA ROCHE AG.: REGIONAL REVENUE

FIGURE 43 EUROFINS SCIENTIFIC.: KEY FINANCIALS

FIGURE 44 EUROFINS SCIENTIFIC.: SEGMENTAL REVENUE

FIGURE 45 EUROFINS SCIENTIFIC.: REGIONAL REVENUE

Cholesterol Test Market

Cholesterol test market is expected grow USD 21.9 Billion at a CAGR 8.3% during the forecast period.

Segmentation

By Product Type Test Kits Test Strips
By Test Type Total Cholesterol Test High Density Lipoprotein (Hdl) Cholesterol Low Density Lipoprotein (Ldl) Cholesterol And Triglycerides/Vldl Cholesterol Test)
By Distribution Channel Over The Counter Prescription Based
By End-User Hospitals & Clinics Homecare Diagnostic Centers

Key Players

  • Quest Diagnostics Incorporated
  • Clinical Reference Laboratory Inc.
  • Randox Laboratories Ltd.
  • PTS DIAGNOSTICS
  • Hoffmann-La Roche AG
  • Cell Biolabs Inc.
  • Laboratory Corporation of America Holdings
  • Thermo Fisher Scientific
  • Alere Inc.
  • Eurofins Scientific

Drivers

  • Growing awareness and adoption of preventive healthcare
  • Increasing incidence of cardiovascular diseases and obesity
  • Government Initiatives to Improve Quality of Testing
Speak to Analyst Request a Free Sample

Cholesterol Test Market Overview


The cholesterol test market is anticipated to grow substantially in the years to come. The cholesterol levels analysis market value is expected to grow at a CAGR (Compound Annual Growth Rate) of about 7.4%. The overall market value is estimated to rise to USD 2.46 Billion by the year 2025. The rising prevalence of cardiovascular diseases or obesity, doctors' choice for lab testing over self-testing, increasing awareness and implementation of preventive healthcare, increasing government funding to improve testing quality, and the rising senior are the main factors propelling the cholesterol test market growth over the forecast years.


A cholesterol test is a sort of blood test that measures the level of each type of cholesterol and specific fats in the blood. Because high levels of low-density lipoprotein blood cholesterol may place the patient at risk for cardiovascular diseases, obesity, and other dangerous illnesses. Cholesterol testing devices are used to assess the amount of cholesterol in patients to prevent the emergence of CVD in the early stages, as these illnesses might clog arteries. Cholesterol is also influenced by the increasing thyroid disease. Changes in lifestyle, as well as a decrease in physical activity daily, have paved the way for these diseases.


Covid-19 Analysis


With the rise of the Covid-19 impact, many large-scale businesses and industries suffered, except healthcare and life support products. The lockdown and physical distancing protocols have affected millions of small and big business institutions alike. Pharmaceutical and biotech businesses, along with governments across the globe, are collaborating to handle the Covid-19 epidemic, from vaccine research to planning for pharmaceutical supply chain issues.


The global population is becoming increasingly obese and their risks of developing cardiovascular ailments as a result of the pandemic COVID-19 breakout and lockdown. In contrast, the government is spending billions of dollars to upgrade healthcare infrastructure and promote a healthier lifestyle, which can be attributed to market growth. Also, the growing elderly population will drive market expansion.


Market Dynamics


Drivers


The rising awareness and implementation of preventive healthcare, the rising prevalence of heart diseases & obesity, the government's initiatives to enhance the testing efficiency, and the world's geriatric population, with the fastest growth in low- and middle-income countries, are expected to drive the growth of the cholesterol test market value.


Opportunities


Developing nations such as India, China, and Japan are spending heavily on healthcare infrastructure, and the requirement for technological progress is posing a potential opportunity for the industry. The key market players are also taking measures to expand their business by adopting industry trends such as product launches, acquisitions, and mergers.


Restraints 


Some factors are predicted to hinder the market share expansion. The advent of non-invasive cholesterol testing technologies may limit the growth of the cholesterol test market over the forecast years. Furthermore, the growing elderly population will lead to market growth, while millions of people may die as a consequence of cardiovascular illnesses, which are expected to increase in the future, acting as a hindrance to market expansion.


Challenges


The absence of healthcare resources in some low-income countries, an inadequately trained staff, and strict safety regulations may act as factors that slow down the market growth. This will further challenge the cholesterol test market share growth over the forecast years.


Cumulative Growth Analysis


The cholesterol test market is anticipated to grow substantially in the years to come. The cholesterol levels analysis market value is expected to grow at a CAGR of about 7.4%. The overall market value is estimated to rise to USD 2.46 Billion by the year 2025. The rising prevalence of cardiovascular diseases or obesity, doctors' choice for lab testing over self-testing, increasing awareness and implementation of preventive healthcare, increasing government funding to improve testing quality, and the rising senior are the main factors fuelling the cholesterol test market growth over the forecast years.


Value Chain Analysis


A lipid panel or lipid profile refers to a complete cholesterol test. The test may determine the quantity of "healthy" and "bad" cholesterol, as well as triglycerides, a form of fat, in a person's blood. Too much LDL cholesterol in the blood can increase the risk of heart disease and other severe illnesses. High LDL levels can lead to the formation of plaque, a fatty material that narrows the arteries and prevents blood flow properly.


The government is investing billions of dollars to develop healthcare infrastructure and promote a healthier lifestyle, which can be attributed to market growth. Likewise, the increasing geriatric population will lead to market growth, and millions of people may die due to cardiovascular diseases, which are expected to rise in the coming decades, which will hinder the market growth.


Moreover, the implementation of self-testing and non-invasive cholesterol analyzing methods will pose a threat to the market growth. Also, a shortage of diagnostic facilities and competent healthcare professionals in underdeveloped nations may slow down market expansion. Also, growing nations like India, China, & Japan are investing heavily in healthcare infrastructure. The need for technological advancements in healthcare is working as an opportunity for market expansion.


Segment Overview


The global cholesterol test market is classified into many segments, such as product type, test type, distribution channel, and end-user. Listed below are the cholesterol test market segments:


By Product Type



  • Test kits

  • Test strips


By Test Type



  • Total cholesterol Test

  • Low-density lipoprotein (LDL) cholesterol

  • High-density lipoprotein (HDL) cholesterol

  • Triglycerides/VLDL cholesterol test


By Distribution Channel 



  • Prescription-based

  • Over-the-counter


By End-user



  • Homecare

  • Hospitals & Clinics

  • Diagnostic Centres

  • Others


Regional Analysis


The cholesterol test market analysis division comprises North America, Europe, Asia Pacific, and the rest of the world. The Americas are the most important regional market. Countries such as the United States have a well-developed healthcare business. Furthermore, one of the primary reasons driving cholesterol test market development over the forecast years is the rising prevalence of stroke in the United States.


Europe is predicted to have the second-largest patient pool for cardiac illnesses & obesity globally. The Asia-Pacific region is expected to grow at the fastest rate in the global cholesterol test market forecast. Stroke is a particularly critical problem in the Asia-Pacific area that comprises more than 60 % of the global population and many growing nations. Due to inadequate healthcare infrastructure and exposure to modern services, the Middle East and Africa will have the smallest market.


Competitive Landscape


The cholesterol test market is dominated by a few companies that play a vital role in the market growth. These cholesterol levels analysis equipment provider companies are called key companies of the market. They contribute to the largest share of the market profit.


The companies account for the market profits by adopting various cholesterol test market trends such as joint ventures, product launches, company expansions, and procurements.


Key Players


Below are the key companies that provide cholesterol level analysis equipment in the global market:



  • Quest Diagnostics Incorporated

  • Clinical Reference Laboratory Inc.

  • Randox Laboratories Ltd.

  • PTS DIAGNOSTICS

  • Hoffmann-La Roche AG

  • Cell Biolabs Inc.

  • Laboratory Corporation of America Holdings

  • Thermo Fisher Scientific

  • Alere Inc.

  • Eurofins Scientific


Recent Developments



  • In 2017, Quest Diagnostics announced a unique, innovative, non-fasting cholesterol testing technique with a better LDL accounting method for increased accuracy and patient comfort.


Report Overview


This report delivers all the information about the global cholesterol test market size in the forecast period. It also contains different sections of the market analysis to help obtain detailed information such as opportunities, challenges, drivers, Covid-19 analysis, regional analysis, competitive landscape, and others. Moreover, all the information is collected from verified primary and secondary sources to provide the expected cholesterol test market outlook by 2027.


Report Details 



  • Historical Period: 2015-2020

  • Base Year: 2021

  • Forecast Period: 2022-2027


Geographically



  • Europe

  • Asia-Pacific

  • North America

  • Middle East & Africa

  • Rest of the world


 



Report Scope:
Report Attribute/Metric Details
  Market Size

  • 2025: USD 2,465 Million
  • 2027: Significant Value
  •   CAGR   7.4% (2018-2025)
      Base Year   2019
      Forecast Period   2025
      Historical Data   2018
      Forecast Units   Value (USD Million)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   by Product Type, Test Type, Distribution Channel and End-User
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Quest Diagnostics Incorporated, Cell Biolabs, Inc., Clinical Reference Laboratory, Laboratory Corporation of America Holdings, Randox Laboratories Ltd., Thermo Fisher Scientific, PTS DIAGNOSTICS Alere Inc., Hoffmann-La Roche AG, Eurofins Scientific
      Key Market Opportunities   Advanced healthcare facilities
      Key Market Drivers

  • Growing awareness and adoption of preventive healthcare
  • Increasing incidence of cardiovascular diseases and obesity
  • Government Initiatives to Improve Quality of Testing


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    The cholesterol test market will generate revenue of USD 2,465 Million by 2025 (future).

    A CAGR of 7.4% is calculated for the growth of the cholesterol test market.

    The rising awareness and adoption of preventive healthcare, coupled with government initiatives to offer advanced healthcare facilities. These are influencing the cholesterol test market growth.

    The cholesterol test market restraints are covered as the emergence of noninvasive cholesterol testing methods.

    Asia-Pacific is the projected region to be the fastest-growing in the cholesterol test market.